BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 27487108)

  • 21. Role of GSTM1 (Present/Null) and GSTP1 (Ile105Val) polymorphisms in susceptibility to acute lymphoblastic leukemia among the South Indian population.
    Suneetha KJ; Nancy KN; Rajalekshmy KR; Sagar TG; Rajkumar T
    Asian Pac J Cancer Prev; 2008; 9(4):733-6. PubMed ID: 19256768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between genotype and enzyme activity of glutathione S-transferases M1 and P1 in Chinese.
    Zhong SL; Zhou SF; Chen X; Chan SY; Chan E; Ng KY; Duan W; Huang M
    Eur J Pharm Sci; 2006 May; 28(1-2):77-85. PubMed ID: 16488119
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between genetic polymorphisms related to DNA repair or xenobiotic pathways and gastric premalignant conditions.
    Tahara T; Shibata T; Nakamura M; Yamashita H; Yoshioka D; Okubo M; Yonemura J; Kamiya Y; Ishizuka T; Nakagawa Y; Nagasaka M; Iwata M; Hirata I; Arisawa T
    Anticancer Res; 2011 Apr; 31(4):1459-65. PubMed ID: 21508403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cisplatin-induced long-term hearing impairment is associated with specific glutathione s-transferase genotypes in testicular cancer survivors.
    Oldenburg J; Kraggerud SM; Cvancarova M; Lothe RA; Fossa SD
    J Clin Oncol; 2007 Feb; 25(6):708-14. PubMed ID: 17228018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA repair gene polymorphisms predict favorable clinical outcome in advanced non-small-cell lung cancer.
    Kalikaki A; Kanaki M; Vassalou H; Souglakos J; Voutsina A; Georgoulias V; Mavroudis D
    Clin Lung Cancer; 2009 Mar; 10(2):118-23. PubMed ID: 19362955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SNPs of GSTM1, T1, P1, epoxide hydrolase and DNA repair enzyme XRCC1 and risk of urinary transitional cell carcinoma in southwestern Taiwan.
    Hsu LI; Chiu AW; Huan SK; Chen CL; Wang YH; Hsieh FI; Chou WL; Wang LH; Chen CJ
    Toxicol Appl Pharmacol; 2008 Apr; 228(2):144-55. PubMed ID: 18199464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GSTA1, GSTM1, GSTP1, and GSTT1 polymorphisms and susceptibility to smoking-related bladder cancer: a case-control study.
    Matic M; Pekmezovic T; Djukic T; Mimic-Oka J; Dragicevic D; Krivic B; Suvakov S; Savic-Radojevic A; Pljesa-Ercegovac M; Tulic C; Coric V; Simic T
    Urol Oncol; 2013 Oct; 31(7):1184-92. PubMed ID: 24075358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Survival analysis in association with GST gene polymorphism and Treatment outcomes of Gemcitabine and Cisplatin/Carboplatin-based chemotherapy among patients with Gallbladder Carcinoma.
    Feroz Z; Kumar R; Tiwari S; Kumar M
    J Cancer Res Ther; 2024 Jan; 20(1):289-296. PubMed ID: 38554336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single nucleotide polymorphisms in glutathione S-transferase P1 and M1 genes and overall survival of patients with ovarian serous cystadenocarcinoma treated with chemotherapy.
    Cong LX; Zhai XH; Wu FX; Zhu DY; Wang AC
    Oncol Lett; 2016 Apr; 11(4):2525-2531. PubMed ID: 27073511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of GSTM1 (Null/Present), GSTP1 (Ile105Val) and P53 (Arg72Pro) genetic polymorphisms and the risk of breast cancer: a case control study from South India.
    Samson M; Swaminathan R; Rama R; Sridevi V; Nancy KN; Rajkumar T
    Asian Pac J Cancer Prev; 2007; 8(2):253-7. PubMed ID: 17696741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic polymorphisms and the efficacy and toxicity of cisplatin-based chemotherapy in ovarian cancer patients.
    Khrunin AV; Moisseev A; Gorbunova V; Limborska S
    Pharmacogenomics J; 2010 Feb; 10(1):54-61. PubMed ID: 19786980
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictive potential role of glutathione S-transferase polymorphisms in the prognosis of breast cancer.
    Wang X; Huang ZH
    Genet Mol Res; 2015 Aug; 14(3):10236-41. PubMed ID: 26345960
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor site- and stage-specific associations between allelic variants of glutathione S-transferase and DNA-repair genes and overall survival in colorectal cancer patients receiving 5-fluorouracil-based chemotherapy.
    Lai CY; Hsieh LL; Sung FC; Tang R; Bai CH; Wu FY; Chiou HY; Yeh CC
    PLoS One; 2013; 8(7):e69039. PubMed ID: 23894404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of GSTP1 and XRCC1 gene polymorphisms with clinical outcomes of patients with advanced non-small cell lung cancer.
    Liu JY; Liu QM; Li LR
    Genet Mol Res; 2015 Aug; 14(3):10331-7. PubMed ID: 26345972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glutathione S-transferases mu 1, theta 1, pi 1, alpha 1 and mu 3 genetic polymorphisms and the risk of colorectal and gastric cancers in humans.
    Martínez C; Martín F; Fernández JM; García-Martín E; Sastre J; Díaz-Rubio M; Agúndez JA; Ladero JM
    Pharmacogenomics; 2006 Jul; 7(5):711-8. PubMed ID: 16886896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictive value of XRCC1 and XRCC3 gene polymorphisms for risk of ovarian cancer death after chemotherapy.
    Cheng CX; Xue M; Li K; Li WS
    Asian Pac J Cancer Prev; 2012; 13(6):2541-5. PubMed ID: 22938418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ERCC1, XRCC1, and GSTP1 Polymorphisms and Treatment Outcomes of Advanced Epithelial Ovarian Cancer Patients Treated with Platinum-based Chemotherapy.
    Liblab S; Vusuratana A; Areepium N
    Asian Pac J Cancer Prev; 2020 Jul; 21(7):1925-1929. PubMed ID: 32711417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Common variants of GSTP1, GSTA1, and TGFβ1 are associated with the risk of radiation-induced fibrosis in breast cancer patients.
    Terrazzino S; La Mattina P; Gambaro G; Masini L; Franco P; Canonico PL; Genazzani AA; Krengli M
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):504-11. PubMed ID: 22079734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platinum/paclitaxel-based chemotherapy in advanced ovarian carcinoma: glutathione S-transferase genetic polymorphisms as predictive biomarkers of disease outcome.
    Medeiros R; Pereira D; Afonso N; Palmeira C; Faleiro C; Afonso-Lopes C; Freitas-Silva M; Vasconcelos A; Costa S; Osório T; Lopes C
    Int J Clin Oncol; 2003 Jun; 8(3):156-61. PubMed ID: 12851839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacogenetic study in rectal cancer patients treated with preoperative chemoradiotherapy: polymorphisms in thymidylate synthase, epidermal growth factor receptor, GSTP1, and DNA repair genes.
    Páez D; Salazar J; Paré L; Pertriz L; Targarona E; del Rio E; Barnadas A; Marcuello E; Baiget M
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1319-27. PubMed ID: 21570215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.